BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership
Published on: Tuesday 12 August 2025
BioMark Diagnostics Inc., a leading developer of liquid biopsy tests for early cancer detection, announced today a strategic Expression of Interest agreement with SAMA CONSULTING SARL to explore the clinical application of BioMark's innovative liquid biopsy platform for lung cancer detection initially in Tunisia and later across the broader North...
